Dexcom (DXCM) Change in Receivables (2010 - 2026)
Dexcom (DXCM) posted quarterly Change in Receivables of $172.1 million for Q2 2026, down 6.77% year-over-year from $184.6 million in Q2 2025, and up 238.12% quarter-over-quarter from -$124.6 million in Q1 2026.
Dexcom (DXCM) Change in Receivables (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Change in Receivables for 17 consecutive years, with $172.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Receivables fell 6.77% year-over-year to $172.1 million; the TTM figure through Jun 2026 stood at -$84.1 million (down 121.21% YoY), while the FY2025 annual figure was $201.9 million, up 476.86% from the prior year.
- Change in Receivables grew to $172.1 million in Q2 2026 per DXCM's latest filing, from -$124.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $187.2 million in Q4 2023 and bottomed at -$237.8 million in Q3 2025.
- Historically, Change in Receivables has averaged $41.4 million across 5 years, with a median of $32.9 million in 2022.
- On a YoY basis, Change in Receivables climbed as much as 2467.24% in 2025 and fell as far as 527.7% in 2025.
- Dexcom's Change in Receivables stood at $148.3 million in 2022, then rose by 26.23% to $187.2 million in 2023, then slumped by 96.05% to $7.4 million in 2024, then jumped by 1335.14% to $106.2 million in 2025, then soared by 62.05% to $172.1 million in 2026.
- Business Quant data shows DXCM's Change in Receivables at $172.1 million in Q2 2026, -$124.6 million in Q1 2026, and $106.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | - |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172.10 Mn |
| Jun 30, 2026 | 172.10 Mn |
| Mar 31, 2026 | -124.60 Mn |
| Mar 31, 2026 | -124.60 Mn |
| Dec 31, 2025 | 106.20 Mn |
| Dec 31, 2025 | 106.20 Mn |
| Sep 30, 2025 | -237.80 Mn |
| Sep 30, 2025 | -237.80 Mn |
| Jun 30, 2025 | 184.60 Mn |
| Jun 30, 2025 | 184.60 Mn |
| Mar 31, 2025 | 148.90 Mn |
| Mar 31, 2025 | 148.90 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 55.60 Mn |
| Sep 30, 2024 | 55.60 Mn |
| Jun 30, 2024 | -33.80 Mn |
| Jun 30, 2024 | -33.80 Mn |
| Mar 31, 2024 | 5.80 Mn |
| Mar 31, 2024 | 5.80 Mn |